Month: July 2021

Announcement no. 17/2021 Change to the Board of Directors of Alm. Brand A/S Alm. Brand A/S (“Alm. Brand”) hereby announces that member of the Board of Directors Flemming Fuglede Jørgensen will resign from the Board of Directors of Alm. Brand effective today. Flemming Fuglede Jørgensen’s vacancy on the Board of Directors will be filled by alternate Tina Schmidt Madsen (director). Contact Please direct any questions regarding this announcement to: Investors and equity analysts:                  Senior Investor Relations OfficerMikael Bo LarsenMobile no. +45 5143 8002        Press:         Head of Media RelationsMaria LindebergMobile no. +45 2499 8455AttachmentAS 17 2021 – Change to the Board of Directors

INVESTOR NEWS NO.23/2021 DFDS reports monthly ferry volumes for freight and passengers to provide insight into the development of volume trends in DFDS’ European route network.DFDS ferry volumes              June   LTM*Freight 2020 2021 Change   2019-20 2020-21 ChangeLane metres, ‘000 3,214 3,840 19.5%   39,457 43,750 10.9%               Passenger 2020 2021 Change   2019-20 2020-21 ChangePassengers, ‘000 78 46 -41.4%   3,728 957 -74.3%*Last twelve months              Ferry – freight: Total volumes in June 2021 were 19.5% above 2020. Net adjustments for structural route changes reduced growth 2.7 ppt to 16.8%. The extraordinary volume growth in June 2021 vs 2020 reflected the recovery from the significant volume reductions in June 2020 caused by lockdowns related to Covid-19. Mediterranean’s...

Cavotec SA will publish its Q2 report 2021, 30 July 2021 at 07:00 CEST.   A conference call, including a short presentation of the report for shareholders, analysts and media will be held 30 July at 10:00 CEST, followed by a Q&A session.  The presentation will be held by Cavotec’s CEO Mikael Norin and CFO Glenn Withers.  We kindly ask you to dial in 5 minutes prior to the start of the conference call. Conference call Dial-in number: SE: +46856642706 UK: +443333009268 US: +16467224902 Weblink: https://tv.streamfabriken.com/cavotec-q2-2021 ENDS For further details please contact: Johan HähnelInvestor Relations ManagerTelephone: +46 70 605 63 34 – Email: investor@cavotec.com This information was submitted for publication, through the agency of the contact person set out above, at 09:00 CEST on 12 July 2021. About CavotecCavotec...

Cavotec has extended its leading position in automated mooring with two major orders for its MoorMaster™ NxG system, one in Sweden – the first order for MoorMaster in a market with considerable growth potential – and the other in neighbouring Finland, where the technology is already well established. The two multi-unit systems incorporate the latest generation MoorMaster, the NxG, and will be installed at either end of a major passenger and vehicle ferry service, at the Port of Kapellskär in Sweden, owned by Port of Stockholm, and the Port of Naantali in Finland. The systems will moor and release Finnlines’ existing Ro/Pax ferries as well as two 235 meter-long Superstar Ro/Pax ferries currently under construction. The vessels will call at each port twice daily. The MoorMaster systems will enable rapid turnaround times for the two vessels,...

                                                                                                                                                                                                            PRESS RELEASE AB SCIENCE ANNOUNCES THE VALIDATION OF ITS RISK MANAGEMENT PLAN BY THE FRENCH NATIONAL AGENCY (ANSM) IN ORDER TO RESTART PATIENT ENROLLMENT IN FRANCE Paris, July 12, 2021, 8am AB Science SA (Euronext – FR0010557264 – AB) announced today that it has been informed by the French National Agency (ANSM) that the measures proposed by AB Science to reinforce patient safety in masitinib trials are acceptable to allow resumption of enrollment in its three ongoing studies; namely, the phase 3 study in mastocytosis (AB15003), the phase 3 study in amyotrophic lateral sclerosis (AB19001), and the phase 2 study in COVID-19...

PARIS and CAMBRIDGE, Mass., July 12, 2021 (GLOBE NEWSWIRE) — Biophytis SA (Nasdaq CM: BPTS, Euronext Growth Paris: ALBPS), (“Biophytis” or the “company”), a clinical-stage biotechnology company focused on the development of therapeutics that are aimed at slowing the degenerative processes associated with aging and improving functional outcomes for patients suffering from age-related diseases, including severe respiratory failure in patients suffering from COVID-19 today announces new positive preclinical data on Sarconeos (BIO101) in hamsters infected with SARS-CoV-2. The data will be presented as an ePoster at the 31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), which will take place online from 9-12 July 2021. This study reveals that Sarconeos (BIO101) daily treatment prevents respiratory function...

REC Silicon ASA (REC Silicon) will release its Q2 2021 results on Thursday, July 22, 2021 at 7:00 a.m. CEST. The same day at 8:00 a.m. CEST, the company will host an audiocast to present the results. Following the presentation, it will be opened for questions from the audience The presentation will be in English. To join the audiocast, use the following link. https://channel.royalcast.com/landingpage/hegnarmedia/20210722_1/ Audiocast participants need to register to post questions. For further information, please contact:Nils O. Kjerstad, IR ContactPhone: +47 9135 6659Email: nils.kjerstad@crux.no About REC Silicon:REC Silicon is a leading producer of advanced silicon materials, delivering high-purity polysilicon and silicon gas to the solar and electronics industries worldwide. We combine over 30 years of experience and proprietary technology...

On 9 July 2021, AB “Ignitis grupė” (hereinafter – the Company) received a rating of AA (on a scale of CCC-AAA) in the MSCI ESG Ratings assessment. This represents an upgrade from the Company’s previous score A, which it held since 2020 and designates the Company as a leader in its industry in managing the most significant ESG risks and opportunities.  MSCI ESG Ratings assessment is based on a company’s resilience to financially material ESG risks. It evaluates a company’s exposure to, and management of, key ESG risks and opportunities. The final ESG rating is an industry-adjusted score, meaning that it is based on a company’s relative performance compared to its global industry peers.  The latest ESG rating by MSCI reflects the Company’s continuous commitment to reducing carbon dioxide emissions to combat climate change, expanding renewable...

Admiral Group plc 12 July 2021 Admiral Group 2021 half year results trading update Based on preliminary figures, Admiral Group (“Admiral” or “The Group”) anticipates a higher than expected Group profit before tax for the first half of 2021 in the range of £450 to £500 million (continuing operations)1. The stronger result is due to unusually positive development in the cost of UK motor bodily injury claims from a number of prior underwriting years which has led to higher reserve releases and profit commission revenue. There has been no change to Admiral’s prudent approach to claims reserving. Further, motor claims frequency in 2021 to date has been lower than expected due to extended lockdown restrictions resulting in a favourable current period loss ratio, despite the significant reductions in Admiral’s premium rates over the past twelve...